Appointment of Non-Executive Director

RNS Number : 9043D

Cambridge Cognition Holdings PLC

01 July 2019

 

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Appointment of Non-Executive Director

The neuroscience technology company, Cambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technologies to assess brain health, is pleased to announce the appointment of Debra Leeves as a Non-Executive Director with immediate effect.

Debra is currently CEO of Vertual, the leading provider of virtual and augmented reality training simulation systems in radiotherapy. She has over 25 years of experience in the medical technology and biotechnology industries, and has previously been COO of Beckley Canopy Therapeutics, CEO of Physeon and also held senior roles with companies such as Rex Bionics, Avita Medical, Merck, GlaxoSmithKline, GE Healthcare and Pfizer.

Matthew Stork, CEO of Cambridge Cognition said:

"We are delighted that Debra has joined the Board. Debra brings with her an immense amount of knowledge and expertise in successful global medical technology businesses and clinical trial management within major pharmaceutical companies.  Her experience will be invaluable as we continue the growth of Cambridge Cognition."

The following information regarding Debra Marie Leeves (aged 57) is disclosed under Schedule 2(g) of the AIM Rules for Companies:

Current Directorships	Directorships held in past 5 years
Vertual Limited Oxford Box Ltd DML Solutions Limited	Physeon GmbH

As at the date of this announcement, Mrs Leeves is not beneficially interested in any Ordinary Shares in the Company.

There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries

Cambridge Cognition Holdings PLC Matthew Stork, Chief Executive Officer Nick Walters, Chief Financial Officer	Tel: [phone] [e-mail]
finnCap Ltd (NOMAD and Joint Broker) Geoff Nash / Simon Hicks Alice Lane / Manasa Patil	Tel: [phone] (Corporate Finance) (ECM)
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant	Tel: [phone]
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Miles Nolan / Zach Cohen	Tel: [phone]

About Cambridge Cognition

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.

For further information visit www.cambridgecognition.com

 

END

 

 

MSCBUGDLCDDBGCI